Ozempic

UVM Health plans to stop covering weight loss medications for employees starting September 2023, aiming to save $19 million annually. The decision affects GLP-1 drugs like Ozempic and Zepbound, which are costly out-of-pocket for employees, while coverage for diabetes treatment remains. Employees express concern over financial burden and health impacts.

Ozempic users over 65 are using the weight loss drug incorrectly, prompting an urgent dosage warning. Dr. Sheila highlights later-life rules that most patients are not informed about.

GLP-1 receptor agonists, including Ozempic, show potential in reducing cancer risk through weight loss, inflammation reduction, and metabolic improvements. Early studies link their use to a 30-35% lower breast cancer incidence in women and reduced risks for colorectal, endometrial, ovarian, liver, and brain cancers.

Experts in Charlotte, N.C., are raising concerns about the disposal of GLP-1 injection pens as the use of weight-loss drugs like Ozempic, Wegovy, and Zepbound surges. Studies estimate roughly 12% of U.S. adults are using these medications, prompting questions about post-use waste management.

GLP-1 drugs caused weight loss and reversed depression-like behavior in mice, according to a study. The findings were highlighted in a blog post and discussed on a news commentary platform.

The viral 'natural Ozempic' drink is a budget-friendly alternative made by mixing gelatin and warm water, consumed 15 to 30 minutes before meals. It is being promoted as a cost-effective option compared to the medication Ozempic.

Doctors, including DR SHEILA, are raising concerns about the long-term use of Ozempic, a GLP-1 weight-loss drug, particularly its effects on young patients.

Brazil's Hypera filed to launch Semavy, a semaglutide pen targeting the same drug class as Novo Nordisk's Ozempic. The Brazilian semaglutide market generates at least R$5bn ($960m) annually, and the drug's patent expired in March 2026. Rival EMS already secured approval for a competing product.

The article provides doctor-backed strategies to enhance Ozempic weight loss for summer vacation, including guidelines on double dosing, dietary recommendations, and debunking myths that hinder progress.

The article discusses the common mistake people make with Ozempic after reaching their 'goal weight,' leading to weight regain, and highlights DR SHEILA's advice on avoiding the GLP-1 phenomenon.

A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza). The study evaluated their effectiveness in a head-to-head analysis.

The article highlights a town in America with extreme obesity issues, featuring oversized burgers, unused gyms, and custom mobility scooters designed to carry 800lb loads. It also examines why the weight-loss drug Ozempic is ineffective in this context.

A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza).

A new meta-study compared three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza) to determine their effectiveness.

A new study suggests that semaglutide, the active ingredient in Ozempic and Wegovy, may strengthen bones in Type 2 diabetes patients by 15%. This effect was described as an unexpected side benefit of the weight loss drugs.

Research suggests weight-loss drugs like Ozempic and Wegovy may help treat or prevent certain cancers. These drugs, part of the GLP-1 class, are now used by one-in-eight American adults.

Jillian Michaels promotes a 30-day detox plan for weight loss without Ozempic, emphasizing that maintaining weight loss requires a major sacrifice.

Weight-loss drugs like Ozempic are linked to cosmetic issues such as 'Ozempic ears' and sagging breasts due to rapid fat loss. Surgeons report increased demand for procedures like panniculectomies, abdominoplasties, and breast lifts to address these concerns. The effects are attributed to GLP-1 medications causing body fat reduction, which impacts skin elasticity and tissue structure.

Weight loss drugs like Ozempic and Wegovy are linked to relationship changes, including reduced intimacy and emotional connection. Therapists and doctors report some users experiencing decreased motivation for previously enjoyed activities. Carrie Krawiec, a therapist from Birmingham Maple Clinic, discusses the impact on couples.

A new study suggests GLP-1 medications like Ozempic and Mounjaro may reduce the likelihood of violent behavior, potentially influencing broader decision-making beyond dietary choices.

A new study suggests that adults taking GLP-1 medications like Ozempic or Wegovy for weight loss are significantly reducing their physical activity, with decreases in daily steps and moderate-to-vigorous exercise. Researchers emphasize that exercise remains essential for preserving strength and long-term health when using these drugs, despite the observed decline in activity.

Amanda Bynes showcased significant weight loss attributed to Ozempic while being seen with her boyfriend.

Medicare will cover weight loss drugs for adults 65 and older starting next month via a temporary government program. Novo Nordisk plans to seek Chinese regulatory approval for its Wegovy weight loss pill soon amid competition from generic drugmakers.

Colorado has received FDA approval to import lower-cost prescription drugs from Canada, aiming to save residents 20-60% on medications like Ozempic and Eliquis. The state is the second in the U.S. to secure such approval, following Florida, and plans to establish a distribution chain within a year.

Colorado has received FDA approval to import lower-cost prescription drugs from Canada, a process initiated by legislation signed in 2019. The state plans to import 20 specific medications, including Ozempic and Eliquis, aiming for savings of up to 60% and $46 million in total over three years.

Stanford researchers found that a single injection of BRP in mice and pigs reduced food intake by up to 50% within an hour. BRP is being explored as an alternative to Ozempic.

Stanford researchers found that a single injection of BRP in mice and pigs reduced food intake by up to 50% within an hour before a meal, suggesting a potential Ozempic alternative.

Accidental GLP-1 medication overdoses have increased significantly, with a nearly 1,500% rise in poison control calls since 2019. Errors often stem from measurement confusion, compounded medications, and inadequate patient education rather than intentional misuse, according to experts like Dr. Ivania Rizo and Dr. Leslie Golden.

A study found that diabetes patients using semaglutide (Ozempic, Wegovy) had a 15% lower risk of fractures compared to others with type 2 diabetes. The analysis reviewed medical records and focused on adults with the condition.

A study suggests GLP-1 drugs like Ozempic may improve male fertility by aiding weight loss, which is linked to increased testosterone and better sperm quality in obese individuals.

Amanda Bynes flaunted her slimmer frame in wild cutout slacks as part of her 40lb weight loss journey using Ozempic.

Trump has secured a peace deal he wanted and publicly criticized Israel’s Netanyahu for lacking judgment. Markets reacted positively to the development.

A person who had been single for 12 years reported a positive change in their love life after using Ozempic, including meeting a romantic partner on a Greek island. Others reportedly experienced similar outcomes.

People taking GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may experience reduced physical activity despite weight loss, according to Fitbit data analysis. Researchers noted declines in daily steps and exercise levels, raising concerns about muscle mass loss and long-term health impacts.

Researchers are discovering new uses for GLP-1 agonist drugs like Mounjaro and Ozempic every other month, including treatment for substance abuse. The article highlights drug repurposing as a technique that saved lives during COVID.

A University of Pennsylvania study found that women taking GLP-1 receptor agonist medications like Ozempic and Wegovy had a 30% lower risk of breast cancer compared to those who did not. Researchers plan to launch a clinical trial to confirm these findings and explore the drugs' potential to prevent cancer recurrence and improve survival rates.

New research on mouse gut microbiomes suggests GLP-1 drugs like Ozempic may reduce depression and anxiety symptoms by altering gut bacteria, specifically increasing Lactobacillus delbrueckii, which produces stress-calming compounds. The study highlights a brain-gut connection linking these diabetes/weight-loss drugs to mood regulation.

California's Senate passed a bill requiring health insurers to cover GLP-1 weight-loss drugs like Ozempic for public employees, but CalPERS opposes it due to projected $437 million premium increases and $187 million state fund costs. Sen. Laura Richardson advocates for a five-year pilot program to cover chronic weight management treatments, citing potential long-term savings from reduced healthcare costs.

AstraZeneca's investigational GLP-1 pill, elecoglipron, demonstrated significant weight loss in a Phase 2 obesity trial (11.2% after 36 weeks) and improved blood sugar control in a diabetes trial (1.74 percentage-point A1C reduction). Results were compared to oral Ozempic, which showed a smaller A1C decrease in the same study.

Experts warn that obesity jabs, such as Ozempic, can lead to muscle loss as a third of the weight loss comes from muscle tissue. A new drug is being developed to mitigate this side effect.